EP1774046A4 - Novel nucleotide and amino acid sequences and assays and methods of use thereof for diagnosis of lung cancer - Google Patents

Novel nucleotide and amino acid sequences and assays and methods of use thereof for diagnosis of lung cancer

Info

Publication number
EP1774046A4
EP1774046A4 EP05857765A EP05857765A EP1774046A4 EP 1774046 A4 EP1774046 A4 EP 1774046A4 EP 05857765 A EP05857765 A EP 05857765A EP 05857765 A EP05857765 A EP 05857765A EP 1774046 A4 EP1774046 A4 EP 1774046A4
Authority
EP
European Patent Office
Prior art keywords
assays
diagnosis
methods
amino acid
acid sequences
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP05857765A
Other languages
German (de)
French (fr)
Other versions
EP1774046A2 (en
Inventor
Sarah Pollock
Zurit Levine
Amit Novik
Dvir Dahary
Rotem Sorek
Amir Toporik
Shirley Sameah-Greenwald
Osnat Sella-Tavor
Alexander Diber
Gad S Cojocaru
Michal Ayalon-Soffer
Shira Walach
Pinchas Akiva
Naomi Keren
Ronen Shemesh
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Compugen USA Inc
Original Assignee
Compugen USA Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Compugen USA Inc filed Critical Compugen USA Inc
Priority claimed from US11/051,720 external-priority patent/US7569662B2/en
Publication of EP1774046A2 publication Critical patent/EP1774046A2/en
Publication of EP1774046A4 publication Critical patent/EP1774046A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
EP05857765A 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences and assays and methods of use thereof for diagnosis of lung cancer Withdrawn EP1774046A4 (en)

Applications Claiming Priority (32)

Application Number Priority Date Filing Date Title
US53912904P 2004-01-27 2004-01-27
US53912804P 2004-01-27 2004-01-27
US58981504P 2004-07-22 2004-07-22
US60730704P 2004-09-07 2004-09-07
US62065604P 2004-10-22 2004-10-22
US62100404P 2004-10-22 2004-10-22
US62087404P 2004-10-22 2004-10-22
US62086804P 2004-10-22 2004-10-22
US62091804P 2004-10-22 2004-10-22
US62085304P 2004-10-22 2004-10-22
US62097404P 2004-10-22 2004-10-22
US62092404P 2004-10-22 2004-10-22
US62067704P 2004-10-22 2004-10-22
US62091604P 2004-10-22 2004-10-22
US62091704P 2004-10-22 2004-10-22
US62097504P 2004-10-22 2004-10-22
US62113104P 2004-10-25 2004-10-25
US62105304P 2004-10-25 2004-10-25
US62811104P 2004-11-17 2004-11-17
US62825104P 2004-11-17 2004-11-17
US62817804P 2004-11-17 2004-11-17
US62816704P 2004-11-17 2004-11-17
US62811204P 2004-11-17 2004-11-17
US62810104P 2004-11-17 2004-11-17
US62813404P 2004-11-17 2004-11-17
US62814504P 2004-11-17 2004-11-17
US62812304P 2004-11-17 2004-11-17
US62818904P 2004-11-17 2004-11-17
US62815604P 2004-11-17 2004-11-17
US63407504P 2004-12-08 2004-12-08
US11/051,720 US7569662B2 (en) 2004-01-27 2005-01-27 Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancer
PCT/IB2005/004037 WO2006131783A2 (en) 2004-01-27 2005-01-27 Polynucleotides, polypeptides, and diagnosing lung cancer

Publications (2)

Publication Number Publication Date
EP1774046A2 EP1774046A2 (en) 2007-04-18
EP1774046A4 true EP1774046A4 (en) 2010-09-15

Family

ID=37450522

Family Applications (1)

Application Number Title Priority Date Filing Date
EP05857765A Withdrawn EP1774046A4 (en) 2004-01-27 2005-01-27 Novel nucleotide and amino acid sequences and assays and methods of use thereof for diagnosis of lung cancer

Country Status (5)

Country Link
EP (1) EP1774046A4 (en)
JP (1) JP2008507261A (en)
AU (1) AU2005320352A1 (en)
CA (1) CA2555509A1 (en)
WO (1) WO2006131783A2 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1831370A4 (en) 2004-12-13 2009-08-12 Alethia Biotherapeutics Inc Polynucleotides and polypeptide sequences involved in the process of bone remodeling
CN102245640B (en) 2008-12-09 2014-12-31 霍夫曼-拉罗奇有限公司 Anti-PD-L1 antibodies and their use to enhance T-cell function
KR101403019B1 (en) 2013-02-25 2014-06-03 서울대학교산학협력단 Novel biomarker for the diagnosis of lung cancer
CN114804550B (en) * 2022-06-10 2023-06-02 安徽新宇环保科技股份有限公司 Sewage treatment regulation and control system based on neural network model
CN115894942B (en) * 2022-11-07 2024-01-12 同济大学 Hyperbranched comb-type polylysine modified by polycaprolactone and application thereof

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004989A2 (en) * 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ID23661A (en) * 1997-08-14 2000-05-11 Novo Nordisk As ANTIMIXROBA COMPOSITION CONTAINING HALOPEROXIDATION OF HALIDA SOURCES AND AMMONIUM SOURCES
US20030170255A1 (en) * 1999-06-30 2003-09-11 Corixa Corporation Compositions and methods for the therapy and diagnosis of lung cancer
AR031250A1 (en) * 2000-07-11 2003-09-17 Corixa Corp COMPOSITIONS AND METHODS FOR THE THERAPY AND DIAGNOSIS OF CANCER DE PULMON
JP2005527180A (en) * 2001-04-18 2005-09-15 プロテイン デザイン ラブス， インコーポレイテッド Lung cancer diagnosis method, composition of lung cancer modifier and screening method
WO2003097666A2 (en) * 2002-05-16 2003-11-27 Euro-Celtique, S.A. Use of gastrin releasing peptide (grp) and its receptor in cancer screening

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003004989A2 (en) * 2001-06-21 2003-01-16 Millennium Pharmaceuticals, Inc. Compositions, kits, and methods for identification, assessment, prevention, and therapy of breast cancer

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
CHO NAM HOON ET AL: "MMP expression profiling in recurred stage IB lung cancer.", ONCOGENE, vol. 23, no. 3, 22 January 2004 (2004-01-22), pages 845 - 851, XP002594104, ISSN: 0950-9232 *
DATABASE EMBASE [online] ELSEVIER SCIENCE PUBLISHERS, AMSTERDAM, NL; 7 September 2002 (2002-09-07), ISOGAI T., YAMAMOTO J.: "Homosapiens cDNA fis, clone PLACE1005783, highly similar to STROMELYSIN-3 precursor", XP002594102, Database accession no. EM_HUM:AK075448 *
DATABASE EMBL [online] 26 January 2001 (2001-01-26), "MR3-GN0153-101100-014-a10 GN0153 Homo sapiens cDNA, mRNA sequence.", XP002594103, retrieved from EBI accession no. EMBL:BF999015 Database accession no. BF999015 *
DATABASE GSP [online] 12 July 2003 (2003-07-12), "Breast Cancer associated protein sequence SEq ID NO: 298", XP002594101, Database accession no. ABR47531 *
DATABASE GSP [online] 22 August 2002 (2002-08-22), "Human ovarian antigen HOPKL1", XP002594292, Database accession no. ABP41861 *
DELEBECQ T J ET AL: "Overexpression level of stromelysin 3 is related to the lymph node involvement in non-small cell lung cancer.", CLINICAL CANCER RESEARCH : AN OFFICIAL JOURNAL OF THE AMERICAN ASSOCIATION FOR CANCER RESEARCH MAR 2000 LNKD- PUBMED:10741738, vol. 6, no. 3, March 2000 (2000-03-01), pages 1086 - 1092, XP002594105, ISSN: 1078-0432 *
GALL A-L ET AL: "Crystal structure of the stromelysin-3 (MMP-11) catalytic domain complexed with a phosphinic inhibitor mimicking the transition-state", JOURNAL OF MOLECULAR BIOLOGY, LONDON, GB LNKD- DOI:10.1006/JMBI.2001.4493, vol. 307, no. 2, 23 March 2001 (2001-03-23), pages 577 - 586, XP004466039, ISSN: 0022-2836 *

Also Published As

Publication number Publication date
CA2555509A1 (en) 2005-07-27
AU2005320352A8 (en) 2009-04-30
AU2005320352A1 (en) 2006-08-31
WO2006131783A2 (en) 2006-12-14
JP2008507261A (en) 2008-03-13
WO2006131783A3 (en) 2009-08-27
AU2005320352A2 (en) 2006-08-31
EP1774046A2 (en) 2007-04-18

Similar Documents

Publication Publication Date Title
IL172297A0 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis iii
EP1973945A4 (en) Novel nucleotide and amino acid sequences, and methods of use thereof for diagnosis
WO2006131928A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
GB2413796B (en) Methods and means for nucleic acid sequencing
HK1154636A1 (en) Preparation of templates for nucleic acid sequencing
WO2004066941A3 (en) Expression profiles for colon cancer and methods of use
ZA200701846B (en) Monocot ahass sequences and methods of use
GB0422551D0 (en) Labelling and sequencing of nucleic acids
WO2005059108A3 (en) Gene expression profiles and methods of use
WO2005032495A3 (en) Gene expression profiles and methods of use
WO2007058968A3 (en) Gene expression profiles and methods of use
WO2006054297A3 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
WO2004078035A3 (en) Expression profiles for breast cancer and methods of use
EP1870711A4 (en) Marker protein for use in diagnosis of pancreatic cancer
EP1774046A4 (en) Novel nucleotide and amino acid sequences and assays and methods of use thereof for diagnosis of lung cancer
EP1954826A4 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
GB0406863D0 (en) Nucleic acid sequencing
WO2005072050A9 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
WO2005072053A9 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of colon cancer
GB0400976D0 (en) Methods of diagnosis
AU2005288710A1 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
IL174465A0 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
EP1732943A4 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancer
IL187946A0 (en) Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
AU2002953431A0 (en) BmpB Novel Nucleotide and Amino Acid Sequences and Diagnostic and Therapeutic Uses Thereof

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

17P Request for examination filed

Effective date: 20060825

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU MC NL PL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL BA HR LV MK YU

DAX Request for extension of the european patent (deleted)
R17D Deferred search report published (corrected)

Effective date: 20090827

RIC1 Information provided on ipc code assigned before grant

Ipc: G01N 33/53 20060101ALI20090911BHEP

Ipc: C12Q 1/68 20060101AFI20090911BHEP

RIC1 Information provided on ipc code assigned before grant

Ipc: G06F 19/00 20060101ALI20100730BHEP

Ipc: G01N 33/48 20060101AFI20100730BHEP

A4 Supplementary search report drawn up and despatched

Effective date: 20100812

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20110213